[
  {
    "ts": "2026-02-15T09:12:48+00:00",
    "headline": "Can JPMorgan’s Downgrade Reshape AtriCure’s (ATRC) Competitive Moat In Cardiac Surgery Devices?",
    "summary": "AtriCure recently faced a shift in analyst sentiment when JPMorgan downgraded the company to Neutral, citing rising competitive pressure on its AtriClip device from Edwards Lifesciences’ planned surgical offering. This change highlights how competition in cardiac surgery devices can quickly alter perceptions of AtriCure’s positioning, even as other analysts maintain positive views on its prospects. We’ll now examine how JPMorgan’s concerns about Edwards Lifesciences’ competitive threat could...",
    "url": "https://finance.yahoo.com/news/jpmorgan-downgrade-reshape-atricure-atrc-091248714.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "89d657a6-a779-3413-bd2a-4f0cb5393790",
      "content": {
        "id": "89d657a6-a779-3413-bd2a-4f0cb5393790",
        "contentType": "STORY",
        "title": "Can JPMorgan’s Downgrade Reshape AtriCure’s (ATRC) Competitive Moat In Cardiac Surgery Devices?",
        "description": "",
        "summary": "AtriCure recently faced a shift in analyst sentiment when JPMorgan downgraded the company to Neutral, citing rising competitive pressure on its AtriClip device from Edwards Lifesciences’ planned surgical offering. This change highlights how competition in cardiac surgery devices can quickly alter perceptions of AtriCure’s positioning, even as other analysts maintain positive views on its prospects. We’ll now examine how JPMorgan’s concerns about Edwards Lifesciences’ competitive threat could...",
        "pubDate": "2026-02-15T09:12:48Z",
        "displayTime": "2026-02-15T09:12:48Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qYSQ6AG4c18KIEG8bfQS1g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mH32bjf22B8VXoaGCZudBg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-downgrade-reshape-atricure-atrc-091248714.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-downgrade-reshape-atricure-atrc-091248714.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ATRC"
            },
            {
              "symbol": "EW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]